Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

被引：30

作者：

Moghbel, Mateen C. ^{[1
]}

Saboury, Babak ^{[1
]}

Basu, Sandip ^{[2
]}

Metzler, Scott D. ^{[1
]}

Torigian, Drew A. ^{[1
]}

Langstrom, Bengt ^{[3
,4
,5
]}

Alavi, Abass ^{[1
]}

机构：

[1] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA

[2] Tata Mem Hosp, Radiat Med Ctr BARC, Bombay 400012, Maharashtra, India

[3] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden

[4] Univ So Denmark, Dept Nucl Med, Odense, Denmark

[5] Univ London Imperial Coll Sci Technol & Med, Ctr Pharmacol & Therapeut, Neuropsychopharmacol Unit, London, England

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 02期

关键词：

MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; DRUG DEVELOPMENT; FDG-PET; DIAGNOSIS; ANGIOPATHY; TOMOGRAPHY; DEMENTIAS; THERAPEUTICS; DEPOSITION;

D O I：

10.1007/s00259-011-1960-4

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：202 / 208

页数：7

共 55 条

[1] Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
Aisen, Paul S.
Gauthier, Serge
Ferris, Steven H.
Saumier, Daniel
Haine, Denis
Garceau, Denis
Anh Duong
Suhy, Joyce
Oh, Joonmi
Lau, Wan C.
Sampalis, John
[J]. ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (01) : 102 - 111
[2] Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Aizenstein, Howard Jay
Nebes, Robert D.
Saxton, Judith A.
Price, Julie C.
Mathis, Chester A.
Tsopelas, Nicholas D.
Ziolko, Scott K.
James, Jeffrey A.
Snitz, Beth E.
Houck, Patricia R.
Bi, Wenzhu
Cohen, Ann D.
Lopresti, Brian J.
DeKosky, Steven T.
Halligan, Edythe M.
Klunk, William E.
[J]. ARCHIVES OF NEUROLOGY, 2008, 65 (11) : 1509 - 1517
[3] [Anonymous], 2011, IEEE 27 CONV EL EL E
[4] The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
Arnold, Steven E.
Hyman, Bradley T.
Flory, Jill
Damasio, Antonio R.
Van Hoesen, Gary W.
[J]. CEREBRAL CORTEX, 1991, 1 (01) : 103 - 116
[5] Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology
Attems, Johannes
Quass, Magdalena
Jellinger, Kurt A.
Lintner, Felix
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 257 (1-2) : 49 - 55
[6] Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Barthel, Henryk
Gertz, Hermann-Josef
Dresel, Stefan
Peters, Oliver
Bartenstein, Peter
Buerger, Katharina
Hiemeyer, Florian
Wittemer-Rump, Sabine M.
Seibyl, John
Reininger, Cornelia
Sabri, Osama
[J]. LANCET NEUROLOGY, 2011, 10 (05) : 424 - 435
[7] Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls
Barthel, Henryk
Luthardt, Julia
Becker, Georg
Patt, Marianne
Hammerstein, Eva
Hartwig, Kristin
Eggers, Birk
Sattler, Bernhard
Schildan, Andreas
Hesse, Swen
Meyer, Philipp M.
Wolf, Henrike
Zimmermann, Torsten
Reischl, Joachim
Rohde, Beate
Gertz, Hermann-Josef
Reininger, Cornelia
Sabri, Osama
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (09) : 1702 - 1714
[8] PATHOLOGICAL-CHANGES IN FRONTAL-CORTEX FROM BIOPSY TO AUTOPSY IN ALZHEIMERS-DISEASE
BENNETT, DA
COCHRAN, EJ
SAPER, CB
LEVERENZ, JB
GILLEY, DW
WILSON, RS
[J]. NEUROBIOLOGY OF AGING, 1993, 14 (06) : 589 - 596
[9] Positron emission tomography microdosing:: a new concept with application in tracer and early clinical drug development
Bergström, M
Grahnén, A
Långström, B
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (5-6) : 357 - 366
[10] Blomquist Gunnar, 2008, Open Neuroimag J, V2, P114, DOI 10.2174/1874440000802010114

← 1 2 3 4 5 6 →